BI
bioAffinity Technologies, Inc.
BIAFW · NASDAQ
$0.45 -27.42% (-$0.17)
1M +685.71%
Market Cap $2.04M
P/E Ratio -
Div. Yield -
ROE 257.27%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.54x
P/S 0.35x
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Op. margin 209.82%
Gross margin 39.57%
FCF margin 194.88%
Quality
10 /100
Poor ROA 199.30%
ROIC 238.03%
Asset turnover 0.77x
Debt
59 /100
Moderate Int. coverage -337.54x
Debt/Equity 0.38x
Current ratio 1.44x
Stability
22 /100
Unstable Profitable years 0
Beta -1.05x
EPS volatility 74.26%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIAFW
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Maria Zannes
Employees
57
Headquarters
San Antonio
Upcoming events
18 NOV
Earnings
Upcoming earnings report